Salmon, Eric ; Université de Liège - ULiège > Centre de Recherches du Cyclotron - Département des sciences cliniques > Neuroimagerie des troubles de la mémoire et révalid. cogn.
BLIN J., BARON J. C., DUBOIS B., PILLON B., CAMBON H., GAMBIER J., AGID Y. Positron emission tomography study in progressive supranuelear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol, 1990, 47 : 747-752.
BLIN J., VIDAILHET M. J., PILLON B., DUBOIS B., FEVE J. R., AGID Y. Corticobasal degeneration : decreased and asymmetrical glucose consumption as studied with PET. Mov Dis, 1992. 7 : 348-354.
BROOKS D.J. Detection of preclinical Parkinson's disease with PET. Neurology, 1991, 41 (suppl 2) : 24-27.
BROOKS D.J. The role of the basal ganglia in motor control : contributions from PET. J Neurol Sci, 1995, 128 : 1-13.
BROOKS D. J., IBANEZ V., SAWLE G.V. Striatal D2 receptor status in Parkinson's disease, striatonigral degeneration and progressive supranuclear palsy, measured with 11C-raclopride and PET. Ann Neurol, 1992a, 31 : 184-192.
BROOKS D. J., PLAYFORD E. D., IBANEZ V., SAWLE G. V., THOMPSON P. D., FINDLEY L. J., MARSDEN C. D. Isolated tremor and disruption of the nigrostriatal dopaminergic system : an (18F)dopa PET study. Neurology, 1992b, 42 : 1554-1560.
BROOKS D. J., SALMON E., MATHIAS C. J., QUINN N., LEENDERS K. L., BANNISTER R., MARSDEN C.D., FRACKOWIAK R.S.J. The relationship between locomotor disability, autonomiC dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomie failure, Parkinson's disease, studied with PET. Brain, 1990, 113 : 1539-1552.
BURN D. J., RINNE J. O., QUINN N. P., LEES A. J., MARSDEN C. D., BROOKS D. J. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome. A 11Cdiprenorphine PET study. Brain, 1995, 118 : 951-958.
BURN D. J., SAWLE G. V., BROOKS D. J. Differential diagnosis of Parkinson's disease, multiple system atrophy, Steele-Richardson-Olszewski syndrome : discriminant analysis of striatal 18Fdopa PET data. J Neurol Neurosurg Psychiatry, 1994, 57 : 278-284.
CALNE D. B., LANGSTON J. W., MARTIN W. R. W. et al. Positron emission tomography after MPTP : observations relating to the cause of Parkinson's disease. Nature, 1985, 317 : 246-248.
DASILVA J. N., KILBOURN M. R., DOMINO E. F. In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography and (11C)tetrabenazine. Synapse, 1993, 14 : 128-131.
DEBEIR M. P., POLLAK P., PASSINGHAM R., LANDAIS P., GERVASON C., CINOTTI L. F. K., FRACKOWIAK R. S. J., MAUGUIÈRE F., BENABID A. L. Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography. Brain, 1993, 116 : 267-279.
EIDELBERG D., MOELLER J. R., DHAWAN V., SPETSIERIS P., TAKIKAWA S. I. T. CHALY T., ROBESON W., MARGOULEFF D., PRZEDBORSKI S., FAHN S. The metabolic topography of parkinsonism. J. Cereb Blood Flow Metab, 1994, 14 : 783-801.
FOSTER N. L., GILMAN S., BERENT S., MORIN E. M., BROWN M. B., KOEPPE R. A. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol, 1988, 24 : 399-406.
FOWLER J. S., VOLKOW N. D., LOGAN J., SCHLYER D. J., MACGREGOR R. R., WANG G. J. et al. Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease : the degree of reversibility of human brain MAO B inhibition by Ro 19 6327. Neurology, 1993, 43 : 1984-1992.
FRISTON K., HOLMES A. P. WORSLEY K. J., POLINE J. B., FRITH C. D., FRACKOWIAK R. S. J. Statisitical parametric maps in functional imaging : a general linear approach. Human Brain Mapping, 1995, 2 : 189-210.
FROST J. J., ROSIER A. J., REICH S.G. Positron emission tomographic imaging of the dopaminergic transporter with 11C-WIN 35,428 reveals marked decline in mild Parkinson's disease. Ann Neuro, 1993, 34 : 423-431.
GARNETT E. S., NAHMIAS C., FIRNAU G. Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography. Can. J Neurol Sci, 1984, 11 : 174-179.
GIBB W. R. G. Dementia and Parkinson's disease. Brit. J Psychiatry, 1989, 154 : 596-614.
GILMAN S., KOEPPE R.A., JUNCK L. KLUIN K. J., LOHMAN M. S., LAURENT R.T. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atropy. Ann Neurol, 1994, 36 : 166-175.
GRAFTON S. T., WATERS C., SUTTON J., LEW M. F., COULDWELL W. Pallidotomy increases activity of motor association cortex in Parkinson's disease : a positron emission tomographic study. Ann Neurol, 1995, 37 : 776-783.
HANTRAYE P., BROWNELL A. L., ELMALEH D. et al. Dopamine fiber detection by (11C)CFT and PET in a primate model of parkinsonism. Neuroreport, 1992, 3 : 265-268.
JAHANSHAHI M., JENKINS I. H., BROWN R. G., MARSDEN C. D., PASSINGHAM R. E., BROOKS D. J. Self-initiated versus externally triggered movements. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain, 1995, 118 : 912-933.
JENKINS I. H., FERNANDEZ W., PLAYFORD E. D. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol, 1992, 32 : 749-757.
KIPPENHAN J. S., BARKER W. W., PASCAL S., NAGEL J., DUARA R. Evaluation of a neural network classifier for PET scans of normal and Alzheimer's disease subjects. J Nucl Med, 1992, 33 : 1459-1467.
KORDOWER J. H., FREEMAN T. B., SNOW B. J., VINGERHOETS F. J., M. E.J., SANBERG P. R., HAUSER R. A., SMITH D. A., NAUERT G. M., PERL D. P. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med, 1995, 332 : 1118-1124.
LEENDERS K. L., SALMON E., TYRREL P., PERANI D., B. D.J., SAGER H., JONES T., MARSDEN C. D., FRACKOWIAK R. S. J. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol, 1990, 47 : 1290-1298.
MARTIN W. R. W., BECMAN J. H., CALNE D. B., ADAM M. J., HARROP R., ROGERS J. G., RUTH T. J. et al. Cerebral glucose metabolism in Parkinson's disease. Can J Neurol Sci, 1984, 11 : 169-173.
MINOSHIMA S., KOEPPE R. A., FREY K. A., KUHL D. E. Anatomical standardization : linear scaling and non-linear warping of functional brain images. J Nucl Med, 1994, 35 : 1528-1537.
MORRISH P. K., SAWLE G. V., BROOKS D. J. Clinical and (18F)dopa PET findings in early Parkinson's disease. J Neurol Neurosurg Psychiatry, 1995, 59 : 597-600.
MORRISH P. K., SAWLE G. V., BROOKS D. J. Regional changes in (18F)dopa metabolism in the striatum in Parkinson's disease. Brain, 1996, 119 : 2097-2103.
PARKER F., TZOURIO N., BLOND S., PETIT H., MAZOYER B. Evidence for a common network of brain strucutures involved in parkinsonian tremor and voluntary repetitive movement. Brain Res, 1992, 584 : 11-17.
PEPPARD R. F., MARTIN W. R. W., CARR G. D., GROCHOWSKI E., SCHULZER M., GUTTMAN M., MCGEER, P. L., PHILLIPS A. G., TSUI J. K. C., CALNE D. B. Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch Neurol, 1992, 49 : 1262-1268.
PERANI D., BRESSI S., TESTA D., GRASSI F., CORTELLI P., GENTRINI S., et al. Clinical-metabolic correlations in multiple system atrophy. Arch Neurol, 1995, 52 : 179-185.
PLAYFORD E. D., JENKINS I. H., PASSINGHAM R. E., NUTT J., FRACKOWIAK R. S. J., BROOKS D. J. Impaired mesial frontal and putamen activation in Parkinson's disease : a PET study. Ann Neurol, 1992, 32 : 151-161.
REMY P., SAMSON Y., HANTRAYE P., FONTAINE A., DEFER G., MANGIN J. F. et al. Clinical correlates of (18F)fluorodopa uptake in five grafted parkinsonian patients. Ann. Neurol, 1995, 38 : 580-588.
RINNE J. O., BURN D. J., MATHIAS C. J., QUINN N. P., MARSDEN C. D., BROOKS D. J. Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol, 1995, 37 : 569-573.
RINNE J. O., LAIHINEN A., NAGREN K. PET demonstrates different behaviour of striatal dopamine D1 and D2 receptors in early Parkinson's disease. J Neurosci Res, 1990, 27 : 494-499.
SALMON E., BROOKS D. J., LEENDERS K. L. A two-compartment description and kinetic procedure for measuring regional cerebral (11C)nomifensine uptake using positron emission tomography. J Cereb Blood Flow Metab, 1991, 10 : 307-316.
SALMON E., VAN DER LINDEN M., FRANCK G. Anterior cingulate and motor network metabolic impairment in progressive supranuclear palsy. Neuroimage, 1997, 5 : 173-178.
SALMON E., MEULEMANS T., VAN DER LINDEN M., DEGUELDRE C., FRANCK G. Anterior cingulate dysfunction in presenile dementia due to progressive supranuclear palsy. Acta neurol Belg 1996, 96 : 247-253.
SALMON E., SADZOT B., MAQUET P., LEMAIRE C., PLENEVAUX A., DAMHAUT P., FRANCK G. Evolution of striatal metabolic and biochemical dysfunction in striatonigral degeneration. J Neurol, 1994, 24 (Suppl 1) : 24.
SAWLE G., BLOOMFIELD P. M., BJÖRKLUND A., BROOKS D. J., BRUNDIN P., LEENDERS K. L. et al. Transplantation of fetal dopamine neurons in Parkinson's disease : PET (18F)6L-fluorodopa studies in two patients with putaminal implants. Ann Neurol, 1992, 31 : 166-173.
SAWLE G. V., BROOKS D. J., MARSDEN C. D., FRACKOWIAK R. S. J. Corticobasal degeneration : a unique pattern of regional cortical oxygen metabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain, 1991, 114 : 541-556.
SCHAPIRO M. B., PIETRINI P., GRADY C. L., BALL M. J., DECARLI C, KUMAR A., KAYE J. A., HAXBY J. V. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease. J Neurol Neurosurg Psychiatry, 1993, 56 : 859-864.
SHINOTOH H., HIRAYAMA K., TATENO Y. Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determine by PET. Adv Neurol, 1993, 60 : 488-493.
TEDROFF J., AQUILONIUS S. M., HARTVIG P. Monoamine reuptake sites in the human brain evaluated in vivo by means of 11C-nomifensine and positron emission tomography : the effects of age and Parkinson's disease. Acta Neurol Scand, 1988, 77 : 192-201.
VINGERHOETS F. J., SNOW B. J., TETRUD J. W., LANGSTON J. W., SCHULZER M., CALNE D. B. Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol, 1994, 36 : 765-770.
WILLS A. J., JENKINS I. H., THOMPSON P. D., FINDLEY L. J., BROOKS D. J. Red nuclear and cerebellar but no olivary activation associated with essential tremor : a positron emission tomographic study. Ann Neurol, 1994, 36 : 636-642.
